Conference Track

Mother-to-Child Transmission and Management of Pediatric HIV Infection

Source: CCO Official Conference Coverage of the 2006 International AIDS Conference

Capsule Summaries

Universal, Free Access to Antiretroviral Therapy Associated With Improved Survival Among Pediatric AIDS Patients in Brazil
Use of HAART in Children in Resource-Limited Settings Provides Survival Benefit Across a Range of Baseline Disease Stages
HAART Dramatically Improves Growth and Body Composition to Above-Normal Levels in HIV-Infected Children
Nevirapine-Based Antiretroviral Therapy Appears Safe, Active in Postpartum Women After 2 Years of Therapy
Abacavir/Lamivudine Sustains Superior Virologic Response vs Abacavir + Zidovudine or Zidovudine/Lamivudine at 5 Years in Treatment-Naive Children
Age, Weight Determine Nevirapine Concentrations in HIV-Infected Children Receiving Divided Adult Formulations of Nevirapine-Containing Fixed Dose Combinations
High Mortality Rates for HIV-Infected and HIV-Exposed Infants in Resource-Limited Settings Call for Expanded Maternal and Infant Care
HAART Associated With Decreased Mortality of HIV-Infected Children
Peripartum Combination Antiretroviral Prophylaxis and Shortening or Eliminating Breast-feeding May Reduce Risk of HIV Transmission From Mother to Child

Expert Analysis

Mother-to-Child Transmission of HIV Infection

Faculty:

James McIntyre, MD
Marie-Louise Newell, MB, MSc, PhD
Karin Nielsen, MD, MPH

Learning Objectives

Upon completion of this activity, participants should be able to:

Review data from recent studies regarding prevention of mother-to-child transmission of HIV infection
Discuss new data on nevirapine prophylaxis of HIV infection
Describe core issues in the treatment of children with HIV in resource-limited settings
Discuss data from studies of breast-feeding HIV-positive mothers

CME CREDIT INFORMATION

Release Date: 11/08/06

Expiration Date: 11/07/07

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.5 Nursing CE credits

Pharmacists: 1.3 contact hours (0.13 CEUs)

Status: Please log in to view status

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.